Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2018

06.08.2018 | Epidemiology

Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database

verfasst von: Arti Parekh, Wei Fu, Chen Hu, Colette J. Shen, Sara Alcorn, Avani D. Rao, Fariba Asrari, Melissa S. Camp, Jean L. Wright

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Many eligible women with invasive breast cancer do not receive recommended adjuvant radiation (RT), despite its role in local control and overall survival. We examined trends in RT use over 10 years, and the impact of sociodemographic factors on the receipt of standard-of-care RT, using the National Cancer Database (NCDB).

Materials/methods

Women under age 70 with invasive breast cancer who underwent BCS from 2004 to 2014 were analyzed. Receipt of RT was evaluated in the whole cohort and by time period to identify temporal trends. Multiple logistic regression models were used to assess associations between factors such as race, insurance status, ethnicity, and receipt of RT.

Results

A total of 501,733 patients met eligibility criteria. The percentage of patients undergoing adjuvant RT increased from 86.7% in 2004 to 92.4% in 2012, and then decreased in 2013 and 2014 to 88.9%. On univariate analysis, patients of white race were significantly more likely to receive RT compared with patients of black race (90.4% vs 86.9%, p < 0.0001), as were non-Hispanic women compared to Hispanic patients (90.2% vs. 85.3%, p < 0.0001). On multivariate analysis, race, ethnicity, insurance status, education level, and age remained significantly associated with receipt of RT. On temporal analysis, gaps remained stable, with no significant improvements over time.

Conclusions

This analysis suggests a recent decline in guideline-concordant receipt of RT in women under 70, and persistent disparities in the use of RT after BCS by race, ethnicity, and socioeconomic factors. These findings raise concern for a recent detrimental change in patterns of care delivery.
Literatur
1.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716CrossRef Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716CrossRef
2.
Zurück zum Zitat Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106CrossRef Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106CrossRef
3.
Zurück zum Zitat Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241CrossRef Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241CrossRef
4.
Zurück zum Zitat Fyles AW, McCready DR, Manchul LA et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351(10):963–970CrossRef Fyles AW, McCready DR, Manchul LA et al (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351(10):963–970CrossRef
5.
Zurück zum Zitat Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387CrossRef Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387CrossRef
6.
Zurück zum Zitat Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM (2015) PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol 16(3):266–273CrossRef Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM (2015) PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol 16(3):266–273CrossRef
9.
Zurück zum Zitat The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission). (2016). A phase II study of breast-conserving surgery without adjuvant radiotherapy for favorable-risk breast cancer. Retrieved from https://Clinicaltrials.gov/ct2 (identification no. NCT02653755) The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission). (2016). A phase II study of breast-conserving surgery without adjuvant radiotherapy for favorable-risk breast cancer. Retrieved from https://​Clinicaltrials.​gov/​ct2 (identification no. NCT02653755)
10.
Zurück zum Zitat Du Xianglin L, Gor BJ (2007) Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis 17(1):122–128PubMedPubMedCentral Du Xianglin L, Gor BJ (2007) Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis 17(1):122–128PubMedPubMedCentral
11.
Zurück zum Zitat Jagsi R, Abrahamse P, Morrow M et al (2010) Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol 28(14):2396–2403CrossRef Jagsi R, Abrahamse P, Morrow M et al (2010) Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol 28(14):2396–2403CrossRef
12.
Zurück zum Zitat Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB (2016) Trend in age and racial disparities in the receipt of postlumpectomy radiation therapy for stage I breast cancer: 2004–2009. Am J Clin Oncol 39(6):568–574CrossRef Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB (2016) Trend in age and racial disparities in the receipt of postlumpectomy radiation therapy for stage I breast cancer: 2004–2009. Am J Clin Oncol 39(6):568–574CrossRef
13.
Zurück zum Zitat Martinez SR, Tseng WH, Shah DR, Canter RJ, Bold RJ (2012) Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer. Med Oncol 29(3):1523–1528CrossRef Martinez SR, Tseng WH, Shah DR, Canter RJ, Bold RJ (2012) Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer. Med Oncol 29(3):1523–1528CrossRef
14.
Zurück zum Zitat Parise CA, Bauer KR, Caggiano V (2012) Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of california. Cancer 118(9):2516–2524CrossRef Parise CA, Bauer KR, Caggiano V (2012) Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of california. Cancer 118(9):2516–2524CrossRef
15.
Zurück zum Zitat Dragun AE, Huang B, Tucker TC, Spanos WJ (2011) Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival. Cancer 117(12):2590–2598CrossRef Dragun AE, Huang B, Tucker TC, Spanos WJ (2011) Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival. Cancer 117(12):2590–2598CrossRef
16.
Zurück zum Zitat McClelland S 3rd, Page BR, Jaboin JJ, Chapman CH, Deville C Jr, Thomas CR (2017) Jr. The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the united states, part 1: African-american patients. Adv Radiat Oncol 2(4):523–531CrossRef McClelland S 3rd, Page BR, Jaboin JJ, Chapman CH, Deville C Jr, Thomas CR (2017) Jr. The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the united states, part 1: African-american patients. Adv Radiat Oncol 2(4):523–531CrossRef
18.
Zurück zum Zitat Darby SC, Ewertz M, Hall P (2013) Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 368(26):2527CrossRef Darby SC, Ewertz M, Hall P (2013) Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 368(26):2527CrossRef
19.
Zurück zum Zitat Dosch AR, Koru-Sengul T, Miao F, Tannenbaum SL, Byrne MM, Wright JL (2014) Racial and ethnic disparities in the diagnosis of breast cancer: changes in presenting stage in minority populations in florida during 1981–2009. Breast Cancer Res Treat 148(2):379–387CrossRef Dosch AR, Koru-Sengul T, Miao F, Tannenbaum SL, Byrne MM, Wright JL (2014) Racial and ethnic disparities in the diagnosis of breast cancer: changes in presenting stage in minority populations in florida during 1981–2009. Breast Cancer Res Treat 148(2):379–387CrossRef
20.
Zurück zum Zitat Freedman RA, Virgo KS, He Y et al (2011) The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 117(1):180–189CrossRef Freedman RA, Virgo KS, He Y et al (2011) The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 117(1):180–189CrossRef
21.
Zurück zum Zitat Peipins LA, Graham S, Young R, Lewis B, Flanagan B (2013) Racial disparities in travel time to radiotherapy facilities in the atlanta metropolitan area. Soc Sci Med 89:32–38CrossRef Peipins LA, Graham S, Young R, Lewis B, Flanagan B (2013) Racial disparities in travel time to radiotherapy facilities in the atlanta metropolitan area. Soc Sci Med 89:32–38CrossRef
Metadaten
Titel
Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database
verfasst von
Arti Parekh
Wei Fu
Chen Hu
Colette J. Shen
Sara Alcorn
Avani D. Rao
Fariba Asrari
Melissa S. Camp
Jean L. Wright
Publikationsdatum
06.08.2018
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4881-0

Weitere Artikel der Ausgabe 1/2018

Breast Cancer Research and Treatment 1/2018 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.